ALKS

#1227
Alkermes Inc. plc
33.98 USD
+0.68%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
33.84
34.03
Intervallo Annuale
25.16
36.48
Variazione giornaliera
+0.68%
Variazione Mensile
+21.53%
Variazione di 6 mesi
+7.84%
Variazione Annuale
+23.74%
Chiusura Precedente
33.75
Apertura
33.84
Bid
Ask
Minimo
33.84
High
34.03
Volume
203
Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche
Trimestrale Annuale
  • Market Capitalization 5.66 B
  • Employee 2 050
  • Founded 1987
  • CEO Richard F. PopsRichard F. Pops
  • Website www.alkermes.com
  • Headquarter Ireland
  • FIGI UNKNOWN
  • Industry Technology
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
19.57
Rapporto prezzo/fatturato
3.2

Alkermes plc

Alkermes plc is a fully-integrated biopharmaceutical company that focuses on developing medicines for psychiatric and neurological disorders. The company was founded in 1987 by Michael Wall. In September 2011 Alkermes, Inc. merged with Elan Drug Technologies, the former drug formulation and manufacturing division of Élan Corporation, plc. The company is headquartered in Dublin, and has an R&D center in Waltham, Massachusetts, and a manufacturing facility in Wilmington, Ohio.

Notizie